Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 3 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 6Genitourinary 3Other hematologic neoplasm 2Lymphoid 2Gastrointestinal 2Other 1Dermatologic 1

Conditions

Colorectal Adenocarcinoma 1Colonic Neoplasms 1

Interventions

Oxaliplatin 300Fluorouracil 273Gemcitabine 238Bevacizumab 235Leucovorin 212Capecitabine 207pembrolizumab 201Irinotecan 159Nivolumab 158Cisplatin 151Specimen Handling 143Magnetic Resonance Spectroscopy 129130-nm albumin-bound paclitaxel 118Paclitaxel 109durvalumab 106Cetuximab 104Radiotherapy 99Drug Therapy 94atezolizumab 93Biopsy 92tislelizumab 81Albumin-Bound Paclitaxel 81Taxes 75lenvatinib 67Folfox protocol 67Carboplatin 66regorafenib 61Blood Specimen Collection 60sintilimab 54Ipilimumab 53

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Cholecalciferol × Gastrointestinal × 1 year × Clear all
NCT02172651 2026-05-13

Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases

Dana-Farber Cancer Institute

Phase EARLY_PHASE1 Recruiting
80 enrolled
Gastrointestinal

Colonic Neoplasms

NCT04094688 2026-03-03

SOLARIS

Alliance for Clinical Trials in Oncology

Phase 3 Active not recruiting
455 enrolled 13 charts
Gastrointestinal

Colorectal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡